Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pituitary Neuroendocrine Tumor”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)UnknownNCT05005715
What this trial is testing

Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery

Who this might be right for
Non-functioning Pituitary Adenoma
Seoul National University Hospital 64
Post-approval studies (Phase 4)Looking for participantsNCT06679816
What this trial is testing

Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors

Who this might be right for
Pituitary AdenomaPituitary Neuroendocrine Tumor
Beijing Tiantan Hospital 882
Not applicableLooking for participantsNCT07463625
What this trial is testing

Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.

Who this might be right for
Cushing DiseaseACTH-producing Pituitary Tumour
Hospices Civils de Lyon 20
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Ended earlyNCT00958841
What this trial is testing

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Who this might be right for
Pancreatic NeoplasmPituitary NeoplasmNelson Syndrome+1 more
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)WithdrawnNCT00003514
What this trial is testing

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Who this might be right for
Merkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more
Burzynski Research Institute
Not applicableNot Yet RecruitingNCT06326853
What this trial is testing

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Who this might be right for
Endocrine DisordersAdiposityPituitary Adenoma+3 more
IRCCS San Raffaele 200
Early research (Phase 1)Ended earlyNCT05364944
What this trial is testing

Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Who this might be right for
AcromegalyGEP-NET
Debiopharm International SA 19
Not applicableStudy completedNCT01840449
What this trial is testing

Somatuline Predictive Factors in Acromegaly and NET

Who this might be right for
AcromegalyNeuroendocrine Tumours
Ipsen 156
Testing effectiveness (Phase 2)WithdrawnNCT04106843
What this trial is testing

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

Who this might be right for
Locally Advanced Adrenal Gland PheochromocytomaLocally Advanced ParagangliomaMetastatic Adrenal Gland Pheochromocytoma+11 more
M.D. Anderson Cancer Center
Not applicableLooking for participantsNCT05254197
What this trial is testing

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

Who this might be right for
Brain Tumor, PrimaryMeningiomaSchwannoma+2 more
Seoul National University Hospital 3,000
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Not applicableNot Yet RecruitingNCT06607198
What this trial is testing

Clinical-pathological Evaluation of Pit-NETs

Who this might be right for
PituitaryCancerNeuroendocrine Tumors
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 940
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Testing effectiveness (Phase 2)Study completedNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 20
Not applicableLooking for participantsNCT06015802
What this trial is testing

Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors

Who this might be right for
Pituitary AdenomaNeuroendocrine Tumors
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Study completedNCT02299089
What this trial is testing

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Who this might be right for
AcromegalyNeuroendocrine Tumors
Camurus AB 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Not applicableActive Not RecruitingNCT03583528
What this trial is testing

DOTATOC PET/CT for Imaging NET Patients

Who this might be right for
Neuroendocrine TumorsInsulinomaGastrinoma+13 more
British Columbia Cancer Agency 800
Post-approval studies (Phase 4)Looking for participantsNCT04081701
What this trial is testing

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

Who this might be right for
CNS TumorsMeningiomaEsthesioneuroblastoma+4 more
Weill Medical College of Cornell University 200
Load More Results